Change search
ReferencesLink to record
Permanent link

Direct link
NSAIDs: eNdocannabinoid stimulating anti-inflammatory drugs?
Umeå University, Faculty of Medicine, Department of Pharmacology and Clinical Neuroscience, Pharmacology.
2012 (English)In: TIPS - Trends in Pharmacological Sciences, ISSN 0165-6147, E-ISSN 1873-3735, Vol. 33, no 9, 468-473 p.Article, review/survey (Refereed) Published
Abstract [en]

Read any pharmacology textbook and the message is clear: nonsteroidal anti-inflammatory drugs (NSAIDs) act by inhibiting the activity of cyclooxygenase (COX) and thereby the production of prostaglandins. However, evidence is accumulating that NSAIDs involve the endocannabinoid system in their actions, and that such effects may pave the way towards the design of new analgesics that are not plagued with the gastrointestinal and cardiovascular adverse actions that are associated with this class of drugs. In this Opinion article, our current understanding of the involvement of the endocannabinoid system in the actions of NSAIDs is described, and the ways in which this can lead to novel drug development is discussed.

Place, publisher, year, edition, pages
2012. Vol. 33, no 9, 468-473 p.
National Category
Pharmacology and Toxicology
URN: urn:nbn:se:umu:diva-61211DOI: 10.1016/ 000308855200003OAI: diva2:565671
Available from: 2012-11-08 Created: 2012-11-07 Last updated: 2012-11-08Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Fowler, Christopher J.
By organisation
In the same journal
TIPS - Trends in Pharmacological Sciences
Pharmacology and Toxicology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 26 hits
ReferencesLink to record
Permanent link

Direct link